import
caus
dilat
cardiomyopathi
dcm
worldwid
type
coxsackieviru
nonenvelop
positivestrand
rna
viru
enteroviru
genu
one
common
agent
viral
myocard
till
effect
treatment
vmc
lack
due
lack
drug
vaccin
lithium
chlorid
licl
appli
clinic
manag
manic
depress
disord
accumul
evid
demonstr
licl
also
effect
antivir
drug
exhibit
antivir
effect
specif
virus
howev
report
evalu
licl
antivir
effect
mice
model
investig
inhibitori
influenc
licl
replic
vitro
vivo
develop
vmc
found
licl
significantli
suppress
replic
hela
via
inhibit
virusinduc
cell
apoptosi
moreov
licl
treatment
vivo
obvious
inhibit
viru
replic
within
myocardium
allevi
acut
myocard
collect
data
demonstr
licl
inhibit
replic
neg
regul
virustrigg
inflammatori
respons
find
expand
antivir
target
licl
provid
altern
agent
viral
myocard
viral
myocard
vmc
disord
affect
myocardiocyt
follow
viral
infect
progress
dilat
cardiomyopathi
heart
failur
young
adult
coxsackieviru
member
enteroviru
genu
picornavirida
wellidentifi
domin
etiolog
factor
caus
viral
myocard
report
case
dilat
cardiomyopathi
vmc
young
adult
children
caus
although
typei
interferon
report
certain
therapeut
effect
treatment
vaccin
success
treat
infect
myocard
lithium
chlorid
licl
appli
psychotrop
antidepress
agent
clinic
manag
manic
depress
disord
sinc
approv
fda
cumul
evid
suggest
licl
particip
mani
cellular
process
cell
gene
express
apoptosi
prolifer
oncogenesi
glycogen
synthesi
inflamm
licl
explor
treat
diabet
alzheim
diseas
ovarian
cancer
well
antimicrobi
infect
prior
investig
also
reveal
licl
exhibit
antivir
effect
certain
virus
eg
coronaviru
herp
simplex
infecti
bronchiti
viru
porcin
reproduct
respiratori
syndrom
prr
felin
caliciviru
given
report
influenc
licl
enterovirus
infect
rare
studi
evalu
antivir
potenti
licl
viral
infect
model
base
anim
high
signific
examin
effect
licl
infect
virusinduc
viral
myocard
mice
therefor
studi
antivir
effect
licl
hela
cell
mous
result
indic
licl
act
potenti
antivir
agent
significantli
inhibit
replic
decreas
virusinduc
cell
apoptosi
moreov
licl
treatment
could
markedli
suppress
cardiac
viru
replic
allevi
progress
myocard
mice
might
expand
licl
new
applic
virusinduc
inflammatori
diseas
weeksold
male
balbc
mice
obtain
shanghai
slac
anim
inc
mice
handl
conform
institut
guidelin
soochow
univers
approv
ethic
committe
professor
yingzhen
yang
key
laboratori
viral
heart
diseas
zhongshan
hospit
shanghai
medic
colleg
fudan
univers
provid
nanci
strain
titter
tcid
assay
hela
cell
hela
celllin
bought
cell
bank
chines
academi
scienc
shanghai
china
maintain
detail
licl
sigma
st
loui
mo
usa
dissolv
dmem
steril
filter
hela
cell
ad
plate
licl
dilut
dmem
without
serum
h
six
well
mock
treat
control
end
incub
period
solut
dmem
put
everi
well
follow
incub
h
od
calcul
use
micropl
reader
rel
cell
viabil
valu
calcul
mean
od
licl
mean
od
control
detail
protocol
rna
isol
rtpcr
primer
sequenc
use
detail
previou
report
cell
apoptosi
analysi
perform
stain
cell
stain
annexin
vfitc
kit
biovis
palo
alto
ca
usa
briefli
cell
infect
moi
treat
licl
h
recov
wash
two
time
use
cold
pb
stain
annexin
v
ad
min
room
temperatur
rt
number
annexin
v
apoptot
cell
analyz
flowjo
softwar
tree
star
process
canto
ii
flow
cytomet
bd
bioscienc
sdspage
immunoblot
analysi
perform
describ
previous
protein
extract
hela
cell
heart
tissu
detect
clone
dako
denmark
weeksold
male
balbc
mice
receiv
intraperiton
inject
tcid
pfu
dose
bodi
weight
surviv
mice
measur
end
test
day
follow
infect
heart
tissu
obtain
detect
histolog
analysi
viru
rna
cytokin
detail
histolog
test
describ
sever
myocard
evalu
five
section
per
heart
use
score
system
grade
inflamm
grade
less
heart
section
involv
grade
grade
grade
grade
evalu
effect
licl
viral
myocard
mous
infect
intraperiton
divid
two
group
micegroup
pb
licl
treatment
consid
effect
dose
licl
cell
mm
fraction
drug
absorb
ip
approxim
bodyweight
mice
licl
mmper
mous
daili
appli
mice
ip
upon
infect
immunohistochemistri
perform
assess
cardiac
level
cleav
accord
manufactur
instruct
mous
rabbit
specif
hrpdab
detect
ihc
kit
abcam
briefli
paraffin
section
heart
incub
primari
antibodi
cleav
cat
cell
signal
technolog
overnight
wash
section
stain
biotinyl
goat
antipolyval
min
room
temperatur
wash
section
incub
streptavidin
peroxidas
dab
substrat
stain
section
imag
nikon
eclips
microscop
five
imag
captur
high
power
field
magnif
randomli
graphpad
prism
softwar
util
analyz
data
test
result
shown
mean
sd
sem
experi
repeat
least
three
time
independ
surviv
rate
analyz
use
surviv
curv
gener
kaplanmei
tool
lonrank
test
student
ttest
appli
compar
two
group
p
valu
p
p
p
consid
statist
signific
previous
report
mm
appli
nontox
concentr
rang
licl
antivir
effect
cell
firstli
detect
cytotox
licl
hela
cell
shown
fig
b
cell
viabil
licl
mm
dose
h
report
licl
could
affect
cell
apoptosi
sever
tumor
celllin
next
analyz
licl
effect
apoptosi
hela
cell
stain
annexin
v
result
flow
cytometri
reveal
compar
control
licl
concentr
mm
mm
could
induc
cell
apoptosi
hela
fig
therefor
chose
concentr
mm
maximum
concentr
licl
antivir
experi
explor
antivir
effect
licl
infect
moi
use
infect
hela
cell
follow
treatment
seri
dose
licl
mm
shown
fig
larg
number
gfp
cell
reflect
viru
replic
observ
upon
infect
licl
treatment
could
significantli
reduc
number
gfp
cell
flow
cytometri
analysi
confirm
reveal
licl
treatment
decreas
gfp
fluoresc
infect
impli
licl
could
inhibit
replic
fig
next
measur
caspid
protein
level
western
blot
viral
rna
express
qpcr
result
show
viral
rna
protein
level
obvious
decreas
licl
treatment
fig
suggest
licl
could
potenti
restrict
replic
hela
cell
firstli
evalu
influenc
licl
attach
hela
cell
licl
differ
dose
mm
mix
mixtur
ad
cell
h
subsequ
chang
medium
pbswash
cell
cultur
h
analyz
qpcr
western
blot
result
show
viral
rna
level
express
alter
treatment
licl
fig
b
next
rule
effect
licl
viral
entri
hela
cell
infect
togeth
licl
treatment
follow
incub
h
subsequ
chang
media
hela
cell
cultur
h
use
carri
western
blot
qpcr
shown
fig
observ
signific
differ
level
viral
rna
capsid
protein
observ
licland
mocktreat
group
result
impli
licl
treatment
influenc
attach
entri
cell
infect
could
induc
cell
apoptosi
licl
report
involv
sever
tumor
cell
apoptosi
intend
explor
impact
licl
virusinduc
cell
apoptosi
shown
fig
licl
treatment
effect
apoptosi
normal
hela
cell
infect
could
significantli
induc
cell
apoptosi
annexin
v
notabl
licl
treatment
obvious
decreas
cell
apoptosi
annexin
v
result
absolut
number
annexin
v
posit
cell
consist
fig
suggest
licl
could
protect
cell
virusinduc
apoptosi
next
establish
myocard
mice
evalu
antivir
effect
licl
viral
infect
vivo
licl
appli
daili
mice
infect
analyz
myocard
cardiac
viral
replic
found
bodyweight
loss
surviv
rate
mice
markedli
improv
mice
treat
licl
fig
b
expect
viral
rna
level
obvious
decreas
heart
mice
licl
treatment
fig
licl
treatment
also
significantli
decreas
activ
serum
creatin
kinas
ck
echocardiograph
measur
show
left
ventricular
eject
fraction
lvef
left
ventricular
fraction
shorten
lvf
markedli
increas
treat
licl
suggest
licl
could
obvious
improv
cardiac
function
fig
e
consist
stain
analysi
display
control
mice
show
sever
myocard
necrot
lesion
inflamm
licl
treatment
significantli
allevi
myocard
less
inflammatori
foci
necrosi
fig
g
ihc
analysi
show
licl
treatment
decreas
express
cleav
caspas
within
myocardium
support
licl
inhibit
virusinduc
cardiomyocyt
apoptosi
fig
verifi
role
licl
inflamm
within
myocardium
analyz
product
proinflammatori
cytokin
heart
qpcr
shown
fig
level
significantli
decreas
licl
inject
antiinflammatori
cytokin
slightli
increas
licl
treatment
fig
thu
result
indic
licl
could
significantli
suppress
replic
inhibit
virusinduc
inflamm
vivo
antidepress
drug
lithium
wellknown
food
drug
administrationapprov
drug
nearli
year
accumul
evid
suggest
licl
divers
function
physiolog
patholog
process
includ
cancerogen
anti
cancerogen
properti
immunestimulatori
immunosuppress
function
sever
studi
explor
role
licl
viru
infect
suggest
licl
inhibit
certain
viru
replic
transmiss
gastroenter
coronaviru
hiv
canin
parvoviru
prrsv
studi
demonstr
licl
also
restrict
infect
vivo
vitro
cumul
evid
indic
licl
act
agonist
enhanc
pathway
inhibit
glycogen
synthas
pathway
competit
mg
regul
wide
rang
cellular
function
includ
protein
translat
cell
cycl
develop
apoptosi
regul
apoptosi
varieti
cell
type
wellknown
interferon
ifn
pathway
play
key
role
viru
replic
also
report
regul
product
howev
evolv
mechan
antagon
ifn
respons
directli
cleav
mav
also
explor
effect
licl
ifn
product
upon
infect
found
express
ifn
alter
infect
hela
cell
licl
treatment
also
influenc
ifn
express
besid
also
check
typei
interferon
respons
mous
periton
macrophag
stimul
found
product
induc
inhibit
licl
treatment
explain
licl
antivir
effect
infect
moreov
seem
inhibit
induc
licl
immun
cell
also
appli
viru
stimuli
found
similar
result
sendai
viru
sev
infect
periton
macrophag
data
shown
wang
et
al
also
report
similar
phenotyp
found
macrophag
licl
attenu
product
ifn
regulatori
factor
activ
induc
lp
polyinosinicpolycytidyl
acid
sev
glycogen
synthas
manner
report
induc
apoptosi
neuron
cell
fibroblast
recent
studi
suggest
role
apoptosi
complic
suggest
induc
apoptosi
infect
cell
contribut
direct
cytopath
effect
vmc
caus
direct
virusinfect
cardiomyocyt
injuri
via
necrosi
apoptosi
virusinduc
inflammatori
respons
apoptosi
suggest
facilit
viral
progeni
spread
j
yuan
et
al
report
infect
activ
pathway
inhibit
suppress
cpe
apoptosi
via
stabil
consist
result
also
demonstr
licl
treatment
could
significantli
inhibit
apoptosi
hela
cell
far
antivir
properti
licl
viral
infectedanim
model
fulli
explor
deepli
explor
role
licl
viral
myocard
mous
reveal
licl
treatment
could
markedli
restrict
viru
replic
heart
tissu
allevi
inflamm
within
myocardium
report
licl
restrict
replic
inhibit
virusinduc
cell
apoptosi
thu
expand
rang
licl
target
moreov
also
confirm
antivir
potenti
licl
heart
vmc
mice
demonstr
licl
potent
protect
mice
myocard
indic
therapeut
target
licl
virusinduc
inflammatori
diseas
anim
experi
perform
accord
soochow
univers
institut
guidelin
studi
approv
ethic
committe
soochow
univers
written
form
euthanasia
mice
perform
carbon
dioxid
inhal
minimum
fear
anxieti
pain
